HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis.

Abstract
Rotator cuff injury (RCI) is a major musculoskeletal disorder in the adult population where inflammation and pain are major contributing factors. Coincidence of other clinical conditions like glenohumeral arthritis aggravates inflammation and delays the healing response. The mechanism and signaling factors underlying the sustenance of inflammation in the rotator cuff joint are largely unknown. The present article aims to elucidate the involvement of inflammatory molecule, TREM-1 (Triggering Receptors Expressed on Myeloid cells-1), and danger-associated molecular patterns (DAMPs), including high mobility group protein 1 (HMGB-1) and RAGE (receptor for advanced glycation end products), in the setting of RCI with respect to the severity of glenohumeral arthritis. Biceps tendons (15 specimens) from the shoulder and blood (11 samples) from patients with glenohumeral arthritis (Group-1, n = 4) and without glenohumeral arthritis (Group-2, n = 11) after RCI surgery were obtained for the study. Molecular and morphological alterations between the groups were compared using histology, immunofluorescence, RT-PCR and flow cytometry. MRI and histomorphology assessment revealed severe inflammation in Group-1 patients while in Group-2 ECM disorganization was prominent without any hallmarks of inflammation. A significant increase in TREM-1 expression in circulating neutrophils and monocytes was observed. Elevated levels of TREM-1, HMGB-1 and RAGE in Group-1 patients along with CD68+ and CD16+ cells confirmed DAMP-mediated inflammation. Expression of TREM-1 in the tendon of Group-2 patients even in the absence of immune cells presented a new population of TREM-expressing cells that were confirmed by real-time PCR analysis and immunofluorescence. Expression of HMGB-1 and RAGE in the biceps tendon from the shoulder of patients without glenohumeral arthritis implied TREM-1-mediated inflammation without involving immune cells, whereas in patients with glenohumeral arthritis, infiltration and the activation of the immune cells, primarily macrophages, release mediators to induce inflammation. This could be the reason for ECM disorganization without the classical signs of inflammation in patients without glenohumeral arthritis.
AuthorsFinosh G Thankam, Matthew F Dilisio, Nicholas E Dietz, Devendra K Agrawal
JournalPloS one (PLoS One) Vol. 11 Issue 10 Pg. e0165492 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID27792788 (Publication Type: Journal Article)
Chemical References
  • HMGB1 Protein
  • Inflammation Mediators
  • Lipopolysaccharide Receptors
  • Membrane Glycoproteins
  • RNA, Messenger
  • Receptor for Advanced Glycation End Products
  • Receptors, IgG
  • Receptors, Immunologic
  • TREM1 protein, human
  • Triggering Receptor Expressed on Myeloid Cells-1
Topics
  • Adult
  • Arthritis (complications)
  • Extracellular Matrix (metabolism)
  • HMGB1 Protein (blood, metabolism)
  • Humans
  • Inflammation (complications, metabolism, pathology, physiopathology)
  • Inflammation Mediators (metabolism)
  • Lipopolysaccharide Receptors (metabolism)
  • Membrane Glycoproteins (blood, genetics, metabolism)
  • Middle Aged
  • Monocytes (metabolism)
  • Neovascularization, Physiologic
  • Neutrophils (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Receptor for Advanced Glycation End Products (blood, metabolism)
  • Receptors, IgG (metabolism)
  • Receptors, Immunologic (blood, genetics, metabolism)
  • Rotator Cuff Injuries (complications, metabolism, pathology, physiopathology)
  • Shoulder
  • Shoulder Joint
  • Tendons (metabolism)
  • Triggering Receptor Expressed on Myeloid Cells-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: